The ability to diagnose a tumor and monitor its progression and response to treatment without the need to obtain a tissue biopsy has been a long-standing goal of cancer management. This capability is now in hand thanks to the technology known as liquid biopsy, currently one of the most exciting sectors of the in vitro diagnostics market.
The term ‘liquid biopsy’ is used to refer to a noninvasive diagnostic test that can identify various types of cancer...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?